Arsenal Medical is advancing multiple programs based on its two proprietary technology platforms: therapeutic foams and AxioCore, a novel, high-throughput nanofiber technology. The company's in situ forming foams provide local therapy for acute hemorrhage and other critical clinical conditions including vascular injury and repair. Arsenal Medical is supported by venture funding, as well as grants from the Department of Defense, National Institute of Standards and Technology's Technology Innovation Program (NIST-TIP) and the Bill & Melinda Gates Foundation.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 06/01/15 | $16,000,000 |
Intersouth Partners North Bridge Venture Partners Polaris Partners | undisclosed |
